Skip to main navigation Skip to search Skip to main content

The risk of thromboembolic events with early intravenous 2- and 4-g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized, double-blind, placebo-controlled, single-center trial

  • Philip C. Spinella*
  • , Kelly Bochicchio
  • , Kimberly A. Thomas
  • , Amanda Staudt
  • , Susan M. Shea
  • , Anthony E. Pusateri
  • , Douglas Schuerer
  • , Jerrold H. Levy
  • , Andrew P. Cap
  • , Grant Bochicchio
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'The risk of thromboembolic events with early intravenous 2- and 4-g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized, double-blind, placebo-controlled, single-center trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science